Stock Analysts’ downgrades for Thursday, January 4th:

Akamai Technologies (NASDAQ:AKAM) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Akamai, a leading provider of content delivery network (CDN) is benefiting from growing adoption of cloud-based security solutions. Management is also optimistic about robust over-the top (OTT) content viewing. The acquisition of Nominum is anticipated to benefit the company’s flagship Enterprise Threat Protector solution. With increased adoption of mobile data/apps and growing mobile data traffic Akamai is well positioned for long-term growth.  Additionally, strong balance sheet and cash flow will help the company in future acquisitions and share repurchase. However, top-line growth continues to be negatively impacted by lower revenues from the large Internet Platform group companies. Moreover, we expect the newly launched products to take some more time to generate meaningful growth. Notably, the shares have underperformed the industry over the past one year.”

Affiliated Managers Group (NYSE:AMG) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Affiliated Managers’ shares have outperformed the industry, over the past six months. This was supported by the company’s impressive earnings surprise history, as it surpassed the Zacks Consensus Estimate in each of the trailing four quarters. The company remains well positioned for growth based on successful partnerships, a diverse product mix and initiatives undertaken to strengthen its retail market operations. Further, inflows are expected to get impetus with broad distribution across channels and product categories. However, pressure on revenues remains a major concern for the company. Also, its use of high levels of debt could restrict it from procuring additional finance for working capital and other purposes.”

BorgWarner (NYSE:BWA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BorgWarner is poised to benefit from its expansion in Asia that will positively impact its sales figure. Also, a strong balance sheet and ample cash flow helps the company to return capital to its shareholders and undertake new acquisitions. Moreover, it has provided a positive guidance for the fiscal 2017. However, the planned sale of the Remy light vehicle aftermarket business resulted in significant expenses. Also, the negative impact from foreign currencies and pressure from OEMs pose concerns. Moreover, over a month, BorgWarner's shares have underperformed in the industry it belongs to.”

Cerner (NASDAQ:CERN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cerner has had an impressive run on the bourses in the last year. We believe that the company has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory markets based on its product strength and enviable track record of adding new clients. Solid growth in the HealtheIntent platform also holds promise. Additionally, a growing percentage of higher margin software in the business mix is expected to drive margins. The company performed impressively in the ambulatory and small hospital markets lately. However, Cerner has been faceing macroeconomic challenges lately. Unfavorable currency translation is also expected to weigh on its sales and earnings in the coming quarters. In recent times, Cerner’s System sales witnessed a major deterioration owing to a decline in technology resale. Furthermore, the HCIT market is highly competitive, which exerts considerable pressure on both pricing and margins.”

CONMED (NASDAQ:CNMD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CONMED has underperformed the broader industry in terms of price performance in the last year. Nevertheless, strength in General Surgery business on the back of strong performances by Advanced Surgical and Endoscopic Technologies buoys optimism. We are also upbeat about the favorable foreign exchange movements. Solid revenue guidance is indicative of brighter prospects. CONMED is also benefiting from the increasing trend of using minimally invasive techniques as a large percentage of the company’s products are designed for these procedures. On the flipside, declining sales from Orthopedic surgery is a concern. The company operates in a highly competitive environment, adding to our woes. Lower healthcare spending buoyed by the ongoing political conundrum in the U.S. healthcare space is a headwind. CONMED’s stock looks a little overvalued at the moment.”

Columbia Sportswear (NASDAQ:COLM) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of Columbia Sportswear have outperformed the industry in the past year on the back of a solid surprise history and sturdy performance of the company’s European wholesale and U.S. direct-to-consumer businesses. In fact, the company’s top- and bottom-line results in the third quarter of 2017 were primarily driven by improved sales in all international regions. Incidentally, the company is on track with Project CONNECT initiative to drive revenues, capture efficiencies, improve marketing processes and lower SG&A costs. Further as part of the company’s marketing initiatives, it has developed several shop-in-shops and enhanced the number of brand presentations in key partner store locations. However, the company has been facing challenges in the U.S. region, especially on its wholesale front. Moreover, the company remains prone to headwinds such as volatility in the prices of several raw materials and currency fluctuations.”

Consolidated Edison (NYSE:ED) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Consolidated Edison has a favorable rate decisions history by regulatory authorities, which will likely encourage it to invest more in infrastructure improvements. It continues to follow a systematic capital investment plan for infrastructure development and the expansion of renewable assets. The company is also making notable progress in generating renewable energy. Moreover, the company outperformed the broader industry in past one year. However, the company faces interest rate risk owing to variable rate debt and to new debt financing needed to fund capital requirements. Also, adverse decisions by the commissions in pending regulatory cases may negatively impact Consolidated Edison’s earnings.”

FedEx (NYSE:FDX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of FedEx have outperformed its industry in 2017. Ushering in further good news, FedEx also outperformed in the second quarter of fiscal 2018 driven by increased package volumes during the current holiday season. Growth was witnessed across all the major segments of the company. In fact, the strong growth of e-commerce is a huge positive for the company. The company's efforts to reward its shareholders through dividend payments and share buybacks are also encouraging. However, the company's operations have been disrupted by the June 2017 cyberattack. Moreover, high costs are hurting the bottom line. Significant investments at the company's Ground unit are pushing up costs. FedEx is also a highly leveraged company.”

FMC (NYSE:FMC) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “FMC Corp. has outperformed the industry it belongs to over a year. The company is seeing strong demand in its Lithium unit and is expanding production capacity to meet growing demand for electric vehicles. The acquisition of a major portion of DuPont's Crop Protection business has also provided a significant growth platform for the company's Agricultural Solutions unit. The company should also gain from its efforts to expand product portfolio. However, FMC Corp. is faced with challenging agriculture market fundamentals, especially in Latin America. It is also exposed to headwind from weak prices in its agriculture unit. The company’s stretched valuation is another concern.”

GlaxoSmithKline (NYSE:GSK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “We are positive on Glaxo’s efforts to develop its pipeline. Performance of new products has been encouraging. Meanwhile, back-to-back approvals of three new products – Trelegy Ellipta, Shingrix and Jucalla – have strengthened Glaxo’s competitive position. However, persistent challenges like stiff competition, genericization and pricing pressure along with slowing growth in emerging markets have been impacting the company’s performance. Meanwhile, its top-selling respiratory product, Advair is also expected to face generic competition in the United States next year, which will further hurt sales. The slowdown in sales of the Consumer Healthcare segment this year is also a concern. Glaxo’s shares underperformed the broader industry in 2017. However, estimates have gone up slightly ahead of Q4 earnings release. The company has a positive record of earnings surprises in recent quarters.”

Harley-Davidson (NYSE:HOG) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Over the past 60 days, the Zacks Consensus Estimate for Harley-Davidson’s quarterly estimates has gone up. The company is making long-term investments with an aim to expand its product portfolio and market its products. This strategy is expected to drive customer growth for the company. Also, an improved financial position enables it to pay dividends and boost shareholder confidence in Harley-Davidson. However, continuous decline in worldwide retail sales, macroeconomic challenges in some regions as well as higher manufacturing costs are a few concerns for the company. Also, in the last six months, Harley-Davidson’s shares have underperformed the industry it belongs to.”

Harris (NYSE:HRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of Harris Corporation have outperformed its industry over the last six months. In fact, stocks like Harris have been buoyed by the possibility of greater military spending by the United States, owing to tensions with North Korea. The company's efforts to reward shareholders through dividends and buybacks are impressive. Multiple multiple contract wins also bode well. However, the company's high debt levels remain a potent threat. Moreover, the company's struggles on the top line front are concerning. The disappointing performance of the Communication Systems unit also raise concerns.”

Pilgrim's Pride (NASDAQ:PPC) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Over the last six months, Pilgrim’s Pride’s shares have outperformed the industry. The company believes that robust sales in the United States as well as favorable product prices will continue to drive revenues in the quarters ahead. Moreover, Moy Park buyout and unique portfolio strategy are also expected to strengthen results in the quarters ahead. Over the last 60 days, Zacks Consensus Estimate for the stock has also moved north for 2018. However, headwinds such as sudden outbreak of a livestock disease, stiff industry rivalry and input price inflation might dent near-term growth scopes.”

Sturm Ruger & Company Inc (NYSE:RGR) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Sturm, Ruger & Co., Inc. is one of the nation’s leading manufacturers of rugged, reliable firearms for the commercial sporting market. As a full-line manufacturer of American-made firearms, Ruger offers consumers over 400 variations of more than 30 product lines, from the ubiquitous 10/22® and Mini-14®, to the new and exciting LCP® II, Mark IV™, Ruger American Pistol®, Ruger Precision Rifle®, SR-556 Takedown®, AR-556® and Ruger American Rifle®. Their awarding-winning products (the Gunsite Scout Rifle, SR9c®, LCR® and LCP®) all prove that Ruger has a rugged, reliable firearm to meet every shooter’s needs. For more than 60 years, Ruger has been a model of corporate and community responsibility. Their motto, Arms Makers for Responsible Citizens®, echoes their commitment to these principles as they work hard to deliver quality and innovative firearms. “

Rio Tinto (NYSE:RIO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Rio Tinto PLC is an international mining company. The Company has interests in mining for aluminum, borax, coal, copper, gold, iron ore, lead, silver, tin, uranium, zinc, titanium, dioxide feedstock, diamonds, talc and zircon. RTZ’s various mining operations are located in New Zealand, Australia, South Africa, Europe and Canada. “

Red Lion Hotels (NYSE:RLH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Red Lion Hotels Corporation, established in 1959, is an international hospitality company primarily engaged in the franchising, management and ownership of upscale, midscale and economy hotels under the Hotel RL, Red Lion Hotels, Red Lion Inn & Suites, GuestHouse, Settle Inn, Vantage Hotels, Americas Best Value Inn, Canadas Best Value Inn, Lexington by Vantage, America’s Best Inns & Suites, Country Hearth Inns, Jameson Inn, Signature Inn and 3 Palms Hotels & Resorts brands. The company also owns and operates an entertainment and event ticket distribution business under the brand name TicketsWest. “

RLJ Lodging Trust (NYSE:RLJ) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “RLJ Lodging Trust is a REIT focused on investing primarily in premium-branded, focused-service, and compact full-service hotels. It plans to own hotels concentrated in urban and dense suburban markets. “

RE/MAX (NYSE:RMAX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Re/Max Holdings, Inc. is a franchisor of real estate brokerage services. Re/Max Holdings, Inc. is based in Denver, CO. “

Rockwell Medical (NASDAQ:RMTI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly. “

Rexahn Pharmaceuticals (NYSEAMERICAN:RNN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn’s compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy. “

Rogers (NYSE:ROG) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Rogers Corporation designs, develops, manufactures and sells high-quality and high-reliability engineered materials and components for mission critical applications. We operate principally three strategic business segments – Advanced Connectivity Solutions, Elastomeric Material Solutions and Power Electronics Solutions. “

Resaas Services (OTCMKTS:RSASF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Resaas Services Inc. engages in the provision of design, development and commercialization of online platforms. The company developed a cloud-based social business software platform for the real estate services industry. Resaas Services Inc. is headquartered in Vancouver, Canada. “

Rosetta Stone (NYSE:RST) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Rosetta Stone Inc., based in Arlington, Va, is a leading provider of technology-based language learning solutions consisting of software, online services and audio practice tools, primarily under the Rosetta Stone brand. Rosetta Stone offers its self-study language learning solutions in 31 languages. Its customers include individuals, educational institutions, armed forces, government agencies and corporations. Rosetta Stone, Inc. also provides an online peer-to-peer practice environment, known as SharedTalk, at www.sharedtalk.com, where registered language learners meet for language exchange to practice their foreign language skills. As the leading language-learning software in the world, Rosetta Stone makes learning a new language second nature. Millions of learners in more than 150 countries have already used the company’s software to gain the confidence that comes with truly knowing a new language. “

Rewalk Robotics (NASDAQ:RWLK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company’s exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. ReWalk Robotics Ltd. is headquartered in Yokneam Ilit, Israel. “

Sino Biopharmaceut (OTCMKTS:SBMFF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Sino Biopharmaceutical Limited researches, develops, produces and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis. Sino Biopharmaceutical Limited is headquartered in Wanchai, Hong Kong. “

Superconductor Technologies (NASDAQ:SCON) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Superconductor Technologies Inc. manufactures and markets high-performance filters to service providers and original equipment manufacturers in the mobile wireless telecommunications industry. The company’s product, the SuperFilter, combines high-temperature superconductors with cryogenic cooling technology to produce a filter with significant advantages over conventional filters. The company was engaged primarily in research and development and generated revenues primarily from government research contracts. “

Sports Direct Intl (OTCMKTS:SDISY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Sports Direct International plc provides retails sports and leisure clothing, footwear, equipment and accessories. The company’s operating segment consists of Sports Retail, Brands and Premium Lifestyle. Sports Direct International plc is headquartered in Shirebrook, the United Kingdom. “

Supergroup Plc, Cheltenham (OTCMKTS:SEPGY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “SuperGroup PLC is involved in the design, production and sale of clothing and accessories for men and women. The companys product consists of T-shirts, polo shirts, hoods and sweats, denim, joggers, tops, dresses, jackets, shirts, knitwear and footwear, as well as bags and accessories. Its brand name includes Superdry. SuperGroup PLC is headquartered in Cheltenham, the United Kingdom. “

Stifel Financial (NYSE:SF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Stifel Financial Corp. is a holding company for Stifel Nicolaus & Company, Incorporated. “

Domtar (NYSE:UFS) (TSE:UFS) was downgraded by analysts at Vertical Group from a buy rating to a hold rating.

Receive News & Ratings for Akamai Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akamai Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.